UMIN ID: UMIN000001044
Registered date:20/02/2008
A late phase II study of multidisciplinary approach to establish standard treatment for advanced neuroblastoma
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | neuroblastoma |
| Date of first enrollment | 2007/03/01 |
| Target sample size | 37 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Chemotherapy, surgery and radiotherapy for high-risk neuroblastoma patients |
Outcome(s)
| Primary Outcome | 3-year progression free survival rate |
|---|---|
| Secondary Outcome | 3-year overall survival rate, the incidence of adverse events |
Key inclusion & exclusion criteria
| Age minimum | 1years-old |
|---|---|
| Age maximum | 18years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Active double cancer, pregnant or possiblly pregnant women and those during breast feeding, patients with psychologic disease or symptoms who have difficulty in receiving protocol treatment, patients with disease that may interfere with the protocol treatment |
Related Information
| Primary Sponsor | Japan Neuroblastoma Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | A research grant from the Ministry of Health, Labor and Welfare |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Masa-aki Kumagai |
| Address | Japan |
| Telephone | |
| kumagai-ma@ncchd.go.jp | |
| Affiliation | National Center for Child Health and Development Division of Hematology |
| scientific contact | |
| Name | Masa-aki Kumagai |
| Address | 2-10-1 Okura, Setagaya-ku, Tokyo, Japan 157-8535 Japan |
| Telephone | 03-3416-0181 |
| Affiliation | National Center for Child Health and Development Division of Hematology |